2023 World Conference on Lung Cancer (Posters)-EP07.02. Navigational Bronchoscopy: Driving to the Nodule Drives Your Patients to Earlier Stage

Pdf Summary

The study examines the use of Ion Navigational Bronchoscopy as a diagnostic intervention for patients with lung nodules. The goal is to improve long-term outcomes for patients with non-small cell lung cancer (NSCLC) by facilitating earlier diagnosis and initiation of definitive therapy. The study evaluates the impact of Ion bronchoscopy on surgical stage and the management of NSCLC patients in an academic community medical center thoracic oncology program.<br /><br />The study includes 568 patients managed with Ion Navigational Bronchoscopy since July 2020. Patients entered through lung screening, lung nodule program, or cancer surveillance. They were evaluated by thoracic surgery and pulmonary medicine. NSCLC patients were included in the analysis. All patients had CT chest for navigation planning and PET scans for staging. Surgical staging with thoracic lymphadenectomy was performed in all patients. Robotic pulmonary resection was performed in 150 patients using Indocyanine Green (ICG) for localization. The study also includes a subsection on the use of Minimally Invasive Diagnosis and Surgery (MIDAS), which includes robotic navigational bronchoscopy and robotic-assisted pulmonary resection under a single episode of anesthesia.<br /><br />The results show that Ion Navigational Bronchoscopy allows for stratification of patients to observation, resection after biopsy, synchronous resection as a single episode of anesthesia, or other definitive therapy. The study found that the use of Ion bronchoscopy shifted the patient population to earlier stages, with 86% of patients being stage I and 96% being stage I or II. This facilitates the implementation of pulmonary parenchymal sparing procedures such as segmentectomy and sublobar resections. The study also highlights the benefits of Ion bronchoscopy, including shortened timelines from nodule identification to definitive therapy, potential reduction in risks associated with multiple anesthetic events, elimination of high anxiety interval between diagnosis and resection, and earlier return to employment and usual lifestyle for patients.<br /><br />Overall, the study demonstrates that Ion Navigational Bronchoscopy is an effective and safe biopsy platform for identifying malignancy and proving benign disease. It plays a crucial role in improving the management of NSCLC patients and optimizing oncologic outcomes.

Asset Subtitle

Patrick Ross

Meta Tag

Speaker Patrick Ross

Topic Early-Stage NSCLC: New Technology & Innovations

Keywords

Ion Navigational Bronchoscopy

diagnostic intervention

lung nodules

non-small cell lung cancer

NSCLC

surgical stage

thoracic oncology program

Minimally Invasive Diagnosis and Surgery

MIDAS

pulmonary resection